2007
DOI: 10.1002/jnr.21394
|View full text |Cite
|
Sign up to set email alerts
|

Noradrenergic regulation in mouse supraoptic nucleus involves a nitric oxide pathway only to regulate arginine‐vasopressin expression and not oxytocin expression

Abstract: Noradrenalin (NA) regulates the expression of arginine-vasopressin (AVP) and oxytocin (OT) by magnocellular neurons in the supraoptic nucleus (SON) of the hypothamalus. Nitric oxide (NO) may be one of the factors involved in the NA signaling pathway regulating AVP and OT expression. To test this possibility, we used an ex vivo experimental model of mouse hypothalamus slices. Increases in AVP and OT levels in the SON were detected by immunohistochemistry and immunoenzyme assays after 1 hr and 4 hr incubations w… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

4
7
0

Year Published

2010
2010
2019
2019

Publication Types

Select...
6

Relationship

3
3

Authors

Journals

citations
Cited by 10 publications
(11 citation statements)
references
References 55 publications
4
7
0
Order By: Relevance
“…Because nNOS may be functionally related to DAPC (Tadayoni et al 2012), we analyzed its expression and activity after DP71 disruption. In wild-type mice, we confirmed previous reports of nNOS in the magnocellular neurons located in the dorsal part of the SON and in the lateral part of the PVN (Vacher et al 2003, Maolood et al 2007. nNOS expression was higher in the SON and PVN of Dp71-null mice, which is similar to what has been reported to occur in response to osmotic stimulation (Kadowaki et al 1994), hypovolemia (Ueta et al 1998), and noradrenalin treatment (Grange-Messent et al 2004, Maolood et al 2007.…”
Section: Nnos Expression and Activitysupporting
confidence: 91%
See 2 more Smart Citations
“…Because nNOS may be functionally related to DAPC (Tadayoni et al 2012), we analyzed its expression and activity after DP71 disruption. In wild-type mice, we confirmed previous reports of nNOS in the magnocellular neurons located in the dorsal part of the SON and in the lateral part of the PVN (Vacher et al 2003, Maolood et al 2007. nNOS expression was higher in the SON and PVN of Dp71-null mice, which is similar to what has been reported to occur in response to osmotic stimulation (Kadowaki et al 1994), hypovolemia (Ueta et al 1998), and noradrenalin treatment (Grange-Messent et al 2004, Maolood et al 2007.…”
Section: Nnos Expression and Activitysupporting
confidence: 91%
“…These functions are fine-tuned by magnocellular activity, and among the different modulatory pathways, the NO pathway is particularly important (Antunes-Rodrigues et al 2004, Grange-Messent et al 2004, Maolood et al 2007. nNOS is expressed at high levels in the SON and PVN (Sagar & Ferriero 1987, Pasqualotto et al 1991, Arévalo et al 1992, Vincent & Kimura 1992) and its expression is functionally regulated by osmotic stimulation ( Kadowaki et al 1994, Villar et al 1994, Ueta et al 1998.…”
Section: Nnos Expression and Activitymentioning
confidence: 99%
See 1 more Smart Citation
“…The expression of AVP and OT in mouse hypothalamus in vivo can be positively regulated by NA (Vacher et al, 2002). We confirmed these data using an ex vivo experimental model involving mouse hypothalamus slices (Maolood et al, 2007).…”
Section: Discussionsupporting
confidence: 78%
“…It modulates the activity of the main afferents to magnocellular neurons (Vacher et al, 2003). There is an NO pathway for a noradrenergic regulation only of AVP expression and not of OT expression in mouse SON (Maolood et al, 2007). Consistently with this work in mice, we previously demonstrated in rat magnocellular neurons short‐term interactions between NA and the activity and expression of NOS, enzymes implicated in the production of NO (Grange‐Messent et al, 2004): NA up‐regulates the neuronal and the inducible NOS in magnocellular neurons, this stimulation leading to NO production by these neurons.…”
Section: Discussionmentioning
confidence: 99%